Skip to main content Scroll Top

Communications orales

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Alzheimer Communications orales
24 octobre 2023
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
ISSC
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
Commotions Communications orales
13 octobre 2023
The RECOVERY study: first results of a pilot clinical trial to evaluate brain photobiomodulation in acute concussion in sportspeople
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer Communications orales
16 septembre 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer Communications orales
2 janvier 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
Relevance of photobiomodulation technique in AD treatment
Relevance of photobiomodulation technique in AD treatment
Alzheimer Communications orales
5 novembre 2020
Relevance of photobiomodulation technique in AD treatment
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Alzheimer Communications orales
2 juillet 2019
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
L’effet neuroprotecteur d’une nouvelle technologie de photobiomodulation réduit la dysbiose du microbiote chez le modèle murin Aβ25-35
L’effet neuroprotecteur d’une nouvelle technologie de photobiomodulation réduit la dysbiose du microbiote chez le modèle murin Aβ25-35
Alzheimer Communications orales
30 janvier 2019
L’effet neuroprotecteur d’une nouvelle technologie de photobiomodulation réduit la dysbiose du microbiote chez le modèle murin Aβ25-35
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
Alzheimer Communications orales
25 janvier 2019
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Alzheimer Communications orales
6 juin 2018
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis